Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis

Published:2011-11 Issue:1 Volume:232 Page:41-52
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Tanaka Kazunori,Kanno Takuya,Yanagisawa Yoshiko,Yasutake Kaori,Hadano Shinji,Yoshii Fumihito,Ikeda Joh-E

Funder

National Institute of Biomedical Innovation

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference47 articles.

1. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis;Barbeito;Brain Res. Brain Res. Rev.,2004

2. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target;Barber;Biochim. Biophys. Acta,2006

3. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target;Barber;Free Radic. Biol. Med.,2010

4. Lost in translation: treatment trials in the SOD1 mouse and in human ALS;Benatar;Neurobiol. Dis.,2007

5. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group;Bensimon;N. Engl. J. Med.,1994

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction;Molecules;2024-07-29

2. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies;European Journal of Medicinal Chemistry;2024-06

3. Prospects of antidiabetic drugs in the treatment of neurodegenerative disease;Brain‐X;2024-02-29

4. Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 Diabetes;Advanced Science;2024-01-29

5. Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery;Cell Stem Cell;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3